These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 6975043)

  • 21. Contraction of guinea pig ileal smooth muscle by acetyl glyceryl ether phosphorylcholine.
    Findlay SR; Lichtenstein LM; Hanahan DJ; Pinckard RN
    Am J Physiol; 1981 Sep; 241(3):C130-3. PubMed ID: 7282914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of the immune response by anaphylatoxins.
    Morgan EL
    Complement; 1986; 3(3):128-36. PubMed ID: 3542364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anaphylatoxin-mediated regulation of human and murine immune responses.
    Morgan EL; Weigle WO; Hugli TE
    Fed Proc; 1984 Jul; 43(10):2543-7. PubMed ID: 6610569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease.
    Belmont HM; Hopkins P; Edelson HS; Kaplan HB; Ludewig R; Weissmann G; Abramson S
    Arthritis Rheum; 1986 Sep; 29(9):1085-9. PubMed ID: 3489467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure and function of the anaphylatoxins.
    Hugli TE
    Springer Semin Immunopathol; 1984; 7(2-3):193-219. PubMed ID: 6387982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a.
    Reed SL; Ember JA; Herdman DS; DiScipio RG; Hugli TE; Gigli I
    J Immunol; 1995 Jul; 155(1):266-74. PubMed ID: 7602103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
    Haeger M; Bengtson A; Karlsson K; Heideman M
    Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anaphylatoxins: possible roles in disease.
    Vogt W
    Complement; 1986; 3(3):177-88. PubMed ID: 3026724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of casoxin C, an ileum-contracting peptide derived from bovine kappa-casein, as an agonist for C3a receptors.
    Takahashi M; Moriguchi S; Suganuma H; Shiota A; Tani F; Usui H; Kurahashi K; Sasaki R; Yoshikawa M
    Peptides; 1997; 18(3):329-36. PubMed ID: 9145417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
    Gerard C; Hugli TE
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a.
    Hugli TE
    Crit Rev Immunol; 1981 Feb; 1(4):321-66. PubMed ID: 7037298
    [No Abstract]   [Full Text] [Related]  

  • 32. Biphasic action of platelet-activating factor on isolated guinea-pig ileum.
    Tokumura A; Harada K; Fukuzawa K; Tsukatani H
    Lipids; 1983 Nov; 18(11):848-50. PubMed ID: 6656539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C3a-induced contraction of guinea pig lung parenchyma: role of cyclooxygenase metabolites.
    Stimler NP; Bloor CM; Hugli TE
    Immunopharmacology; 1983 Feb; 5(3):251-7. PubMed ID: 6403485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of anaphylatoxins through proteolytic processing of C3 and C5 by house dust mite protease.
    Maruo K; Akaike T; Ono T; Okamoto T; Maeda H
    J Allergy Clin Immunol; 1997 Aug; 100(2):253-60. PubMed ID: 9275149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet-activating factor-mediated contraction of rabbit lung strips: pharmacologic modulation.
    Camussi G; Montrucchio G; Antro C; Bussolino F; Tetta C; Emanuelli G
    Immunopharmacology; 1983 Aug; 6(2):87-96. PubMed ID: 6885382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the complement anaphylatoxins in inflammation and hypersensitivity reactions in the lung.
    Stimler-Gerard NP
    Surv Synth Pathol Res; 1985; 4(5-6):423-42. PubMed ID: 3879815
    [No Abstract]   [Full Text] [Related]  

  • 37. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ; Das C; Bennett D; Terman DS
    J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anaphylatoxin-induced release of histamine from in vitro perfused guinea pig kidney.
    Abdullah NA; Assem ES; Damerau B
    Agents Actions; 1988 Apr; 23(3-4):181-4. PubMed ID: 2455983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anaphylatoxins: C3a and C5a.
    Hugli TE; Müller-Eberhard HJ
    Adv Immunol; 1978; 26():1-53. PubMed ID: 358800
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of the anaphylatoxins C3a and C5a on isolated mast cells from rat and man.
    Jürgensen H; Behrendt H; Damerau B; Schmutzler W
    Agents Actions; 1986 Apr; 18(1-2):153-4. PubMed ID: 2425572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.